164 results
Page 5 of 9
CORRESP
6ucok m41uauo
10 Nov 10
Correspondence with SEC
12:00am
CORRESP
9fkddv2lixyc0v5
8 Nov 10
Correspondence with SEC
12:00am
424B5
6v979tk 0epr
13 Oct 10
Prospectus supplement for primary offering
12:00am
424B5
egfqah29 opxa
18 Jun 10
Prospectus supplement for primary offering
12:00am
424B5
7sovkowodno3idz
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
o22ph4 1lctti
15 Jun 10
Prospectus supplement
12:00am
424B5
4r61alhe
28 Apr 10
Prospectus supplement for primary offering
12:00am
424B5
a8lyp4a5 qom
19 Feb 10
Prospectus supplement for primary offering
12:00am
424B5
yogphnizjzy1epg5n
17 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
6xuxr
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.1
t9xn 1eul
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
8-K
EX-99.1
jk6hzi0hxbt1zuaj0
11 Sep 09
Other Events
12:00am
8-K
EX-99.1
djxslo9tx1jpym
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-99.1
0lsxzk x5u4o3tl038
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am